Current Clinical and Pre-Clinical Imaging Approaches to Study the Cancer-Associated Immune System
In the light of the success and the expected growth of its arsenal, immuno-therapy may become the standard neoadjuvant procedure for many cancers in the near future. However, aspects such as the identity, organization and the activation status of the peri- and intra-tumoral immune cells would repres...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-09-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.716860/full |
| _version_ | 1818729090273771520 |
|---|---|
| author | Christopher G. Mueller Christian Gaiddon Aïna Venkatasamy Aïna Venkatasamy |
| author_facet | Christopher G. Mueller Christian Gaiddon Aïna Venkatasamy Aïna Venkatasamy |
| author_sort | Christopher G. Mueller |
| collection | DOAJ |
| description | In the light of the success and the expected growth of its arsenal, immuno-therapy may become the standard neoadjuvant procedure for many cancers in the near future. However, aspects such as the identity, organization and the activation status of the peri- and intra-tumoral immune cells would represent important elements to weigh in the decision for the appropriate treatment. While important progress in non-invasive imaging of immune cells has been made over the last decades, it falls yet short of entering the clinics, let alone becoming a standard procedure. Here, we provide an overview of the different intra-vital imaging approaches in the clinics and in pre-clinical settings and discuss their benefits and drawbacks for assessing the activity of the immune system, globally and on a cellular level. Stimulated by further research, the future is likely to see many technological advances both on signal detection and emission as well as image specificity and resolution to tackle current hurdles. We anticipate that the ability to precisely determine an immune stage of cancer will capture the attention of the oncologist and will create a change in paradigm for cancer therapy. |
| first_indexed | 2024-12-17T22:40:21Z |
| format | Article |
| id | doaj.art-24fe603f6808498385130df6205f42d5 |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-12-17T22:40:21Z |
| publishDate | 2021-09-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-24fe603f6808498385130df6205f42d52022-12-21T21:29:57ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-09-011210.3389/fimmu.2021.716860716860Current Clinical and Pre-Clinical Imaging Approaches to Study the Cancer-Associated Immune SystemChristopher G. Mueller0Christian Gaiddon1Aïna Venkatasamy2Aïna Venkatasamy3CNRS UPR 3572, University of Strasbourg, Immunologie-Immunopathologie-Chimie Thérapeutique, Strasbourg, FranceInserm UMR_S 1113, University of Strasbourg, Interface de Recherche Fondamentale et Appliquée en Cancérologie (IRFAC), Strasbourg, FranceInserm UMR_S 1113, University of Strasbourg, Interface de Recherche Fondamentale et Appliquée en Cancérologie (IRFAC), Strasbourg, FranceIHU-Strasbourg (Institut Hospitalo-Universitaire), Strasbourg, FranceIn the light of the success and the expected growth of its arsenal, immuno-therapy may become the standard neoadjuvant procedure for many cancers in the near future. However, aspects such as the identity, organization and the activation status of the peri- and intra-tumoral immune cells would represent important elements to weigh in the decision for the appropriate treatment. While important progress in non-invasive imaging of immune cells has been made over the last decades, it falls yet short of entering the clinics, let alone becoming a standard procedure. Here, we provide an overview of the different intra-vital imaging approaches in the clinics and in pre-clinical settings and discuss their benefits and drawbacks for assessing the activity of the immune system, globally and on a cellular level. Stimulated by further research, the future is likely to see many technological advances both on signal detection and emission as well as image specificity and resolution to tackle current hurdles. We anticipate that the ability to precisely determine an immune stage of cancer will capture the attention of the oncologist and will create a change in paradigm for cancer therapy.https://www.frontiersin.org/articles/10.3389/fimmu.2021.716860/fullimagingimmune cellscancerlymph nodetertiary lymphoid structure |
| spellingShingle | Christopher G. Mueller Christian Gaiddon Aïna Venkatasamy Aïna Venkatasamy Current Clinical and Pre-Clinical Imaging Approaches to Study the Cancer-Associated Immune System Frontiers in Immunology imaging immune cells cancer lymph node tertiary lymphoid structure |
| title | Current Clinical and Pre-Clinical Imaging Approaches to Study the Cancer-Associated Immune System |
| title_full | Current Clinical and Pre-Clinical Imaging Approaches to Study the Cancer-Associated Immune System |
| title_fullStr | Current Clinical and Pre-Clinical Imaging Approaches to Study the Cancer-Associated Immune System |
| title_full_unstemmed | Current Clinical and Pre-Clinical Imaging Approaches to Study the Cancer-Associated Immune System |
| title_short | Current Clinical and Pre-Clinical Imaging Approaches to Study the Cancer-Associated Immune System |
| title_sort | current clinical and pre clinical imaging approaches to study the cancer associated immune system |
| topic | imaging immune cells cancer lymph node tertiary lymphoid structure |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2021.716860/full |
| work_keys_str_mv | AT christophergmueller currentclinicalandpreclinicalimagingapproachestostudythecancerassociatedimmunesystem AT christiangaiddon currentclinicalandpreclinicalimagingapproachestostudythecancerassociatedimmunesystem AT ainavenkatasamy currentclinicalandpreclinicalimagingapproachestostudythecancerassociatedimmunesystem AT ainavenkatasamy currentclinicalandpreclinicalimagingapproachestostudythecancerassociatedimmunesystem |